Caresyntax
Caresyntax offers AI-powered software, devices, and clinical services designed to enhance surgical outcomes. With a significant global presence in operating rooms, their technology has been utilized in millions of surgeries and boasts a substantial user base of surgical professionals.
Endeavor Biomedicines
Endeavor’s ENV-101 is a second-generation Hedgehog inhibitor with a highly favorable efficacy and side-effect profile compared to the molecules currently in the market. ENV-101 inhibits target pathway by ~90% at all tested doses.
Enquyst Technologies
Enquyst Technologies is developing the next-generation biopharmaceutical manufacturing platform which aims to redesign the downstream bioprocess equipment to bring unprecedented advantages in cost, time, footprint, and speed to market at commercial scale.
